Kariuki, S., Revathi, G., Corkill, J., et al. (2007) Escherichia coli from Community-Acquired Urinary Tract Infections Resistant to Fluoroquinolones and Extended-Spectrum Beta-Lactams. The Journal of Infection in Developing Countries, 1, 257-262.
https://doi.org/10.3855/jidc.361

has been cited by the following article:

• TITLE: Multi-Drug Resistance Pattern of Lactose Non-Fermenting Escherichia coli as Causative Agent of Urine Tract Infections in Luanda, Angola

  AUTHORS: Aleksey Shatalov

  KEYWORDS: Escherichia coli, Multi-Drugs Resistance (MDR), Lactose Non-Fermenting, Urine Tract Infections, Colony Forming Unit (CFU)

  JOURNAL NAME: Open Journal of Medical Microbiology, Vol.9 No.1, January 28, 2019

  ABSTRACT: This prospective study was carried out to assess the sensitivity and resistance pattern of lactose non-fermenting Escherichia coli from July 2018 to December 2018 in the Laboratory of Microbiology at Luanda Medical Center, Angola. Out of 1170 patient, a total of 120 urine specimens infected with Escherichia coli (>105 CFU/ml) were collected according to the routine protocol of urinalysis. Among these 120 isolates, 25 (21%) isolates were determined as “atypical”, lactose non-fermenting E. colis trains. The twenty-five lactose non-fermenting Escherichia coli strains isolated from urine samples in Luanda Medical Center were declared as Multiple Drugs-Resistant strains with high resistance to Cefalexine (100%), Cefuroxime (100%), Ceftriaxone (92%), Gentamycin (92%), Ciprofloxacin (72%) and Amoxiciclin/Clavulanic (80%). The alarming resistance level to the first-choice drugs for the treatment of urinary tract infections caused by non-fermentative lactose E. coli was observed.